Biotech

All Articles

Vaccine and Keytruda combo reliable in squamous cell cancer

.Immune system gate preventions are the superheroes of cancer therapy. Medications like Bristol Myer...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of significant management hirings, firings as...

Regeneron's Opdualag opponent shows 57% feedback price

.Regeneron is back along with lasting consequence for its own LAG-3 prevention as well as PD-1 preve...

AstraZeneca posts records on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed a very early check out the performance of its internal antibody-...

iTeos- GSK's TIGIT celebrity reveals significant enhancement

.After revealing a stage 3 launch based on beneficial midstage results, iTeos and also GSK are final...

More collective FDA can easily accelerate unusual ailment R&ampD: file

.The FDA must be even more open as well as collective to let loose a surge in approvals of uncommon ...

Zenas, MBX, Bicara head to Nasdaq in warm time for biotech IPOs

.It is actually an uncommonly busy Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara The...

Atea's COVID antiviral fails to stop hospital stays in phase 3

.Atea Pharmaceuticals' antiviral has actually neglected an additional COVID-19 trial, yet the biotec...

Neurocrine's quote to save schizophrenia possibility falls short

.Neurocrine Biosciences' mental illness plan pivot has actually failed. The biotech was not able to ...

Sanofi pays out $110M upfront for late-stage radioligand treatment

.Sanofi has actually created a late entrance to the radioligand celebration, paying out 100 million ...